Related Experiment Video
Updated: May 24, 2026
07:16
Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
TSLP signaling network revealed by SILAC-based phosphoproteomics.
Jun Zhong1, Min-Sik Kim, Raghothama Chaerkady
1McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 N Broadway, Baltimore, 21205 Maryland, USA.
Molecular & Cellular Proteomics : MCP
|February 21, 2012
Summary
Thymic stromal lymphopoietin (TSLP) signaling, crucial for immune responses, was mapped using phosphoproteomics. This study identified novel kinase and phosphatase targets, revealing potential therapeutic avenues for TSLP-driven diseases like asthma and leukemia.
Area of Science:
- Immunology
- Cellular Signaling
- Proteomics
Background:
- Thymic stromal lymphopoietin (TSLP) is a key cytokine regulating immune responses.
- TSLP signaling, mediated by a heterodimeric receptor (IL-7Rα and TSLPR/CRLF2), is implicated in diseases like asthma and leukemia.
- A comprehensive understanding of TSLP-activated signaling pathways is currently lacking.
Purpose of the Study:
- To perform a global quantitative phosphoproteomic analysis of the TSLP signaling network.
- To identify novel phosphoproteins and signaling nodes modulated by TSLP.
- To uncover potential therapeutic targets for diseases associated with aberrant TSLP signaling.
Main Methods:
- Global quantitative phosphoproteomic analysis using stable isotope labeling by amino acids in cell culture (SILAC).
- Enrichment of phosphopeptides using titanium dioxide and antiphosphotyrosine antibodies.
- Co-immunoprecipitation assays and kinase inhibitor screening.
Main Results:
- Identified 4164 phosphopeptides on 1670 phosphoproteins, with 226 proteins showing TSLP-modulated phosphorylation.
- First-time identification of TSLP-induced activation of Src and Tec family kinases (Btk, Lyn, Tec) and protein phosphatases (SHP-1, Shp2).
- Demonstrated TSLP-dependent binding of Shp2 to Gab2, forming an inducible protein complex, and identified PI-3 kinase, Jak, Src, and Btk as key kinases in TSLP-driven proliferation.
Conclusions:
- This phosphoproteomic study significantly expands the understanding of the TSLP signaling pathway.
- Novel TSLP-activated kinases and phosphatases, including Shp2/Gab2 complex, have been identified.
- Inhibition of PI-3 kinase, Jak, Src, or Btk kinase pathways represents promising therapeutic strategies for TSLP/TSLPR-associated diseases.
